Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Atomix LLC
WARNING LETTER
•Atomix LLC•November 30, 2025

Atomix LLC – FDA Warning Letter, Nov 30, 2025

Record Details

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Atomix LLC on December 12, 2025, following a review of the company"s website and social media in November 2025. The FDA identified that Atomix LLC is illegally marketing and distributing products containing selective androgen receptor modulators (SARMs), specifically "MK-2866" (Ostarine/Enobosarm) and "RAD-140" (Testolone). Despite claims of "RESEARCH USE ONLY," evidence from product labeling and online content clearly indicates these products are intended for human use, promoting effects like muscle growth, strength enhancement, and bone health, classifying them as drugs under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

These SARM products are considered unapproved new drugs under sections 505(a), 201(g)(1), and 201(p) of the FD&C Act, as they lack FDA approval and are not generally recognized as safe and effective for their intended uses. The FDA highlighted significant safety concerns associated with SARMs, including potential liver toxicity, increased risk of heart attack, and stroke. Introducing these unapproved drugs into interstate commerce violates sections 301(d) and 505(a) of the FD&C Act. Atomix LLC is required to respond within fifteen working days, detailing corrective actions taken, measures to prevent recurrence, and supporting documentation. Failure to comply may result in further regulatory action.

Company
Atomix LLC
Inspection date
November 30, 2025
Product type
Drugs
Office
Office of Unapproved Drugs & Labeling Compliance
People
  • Andrew Pierce
  • Tina Smith (Director)
View Company Profile

ID · 9b48123b-4b5f-441a-967d-353cad3c5cb5

Violation Codes10
21.U.S.C. 355(a)21 U.S.C. 321(g)(1)FD&C Act 505FD&C Act 301(d)21 CFR 201.12821 U.S.C. 35521 U.S.C. 331(d)FD&C Act 201(p)FD&C Act 505(a)FD&C Act 201(g)(1)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Atomix LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.